These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7339821

  • 1. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ, Jones DB, Wiss K.
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
    Wallace RJ, Wiss K, Bushby MB, Hollowell DC.
    Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
    [Abstract] [Full Text] [Related]

  • 3. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ, Swenson JM, Silcox VA, Bullen MG.
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [Abstract] [Full Text] [Related]

  • 4. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.
    Stone MS, Wallace RJ, Swenson JM, Thornsberry C, Christensen LA.
    Antimicrob Agents Chemother; 1983 Oct; 24(4):486-93. PubMed ID: 6651277
    [Abstract] [Full Text] [Related]

  • 5. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
    Wallace RJ, Dalovisio JR, Pankey GA.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):611-4. PubMed ID: 526002
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ, Rodriguez FC, Benavente MC.
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents.
    Casal MJ, Rodriguez FC.
    Ann Microbiol (Paris); 1983 Feb; 134A(1):73-8. PubMed ID: 6847037
    [Abstract] [Full Text] [Related]

  • 8. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ, Hull SI, Bobey DG, Price KE, Swenson JM, Steele LC, Christensen L.
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [Abstract] [Full Text] [Related]

  • 9. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.
    Swenson JM, Thornsberry C, Silcox VA.
    Antimicrob Agents Chemother; 1982 Aug; 22(2):186-92. PubMed ID: 6927280
    [Abstract] [Full Text] [Related]

  • 10. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD, Solomon RJ.
    Am Rev Respir Dis; 1979 Jul; 120(1):197-201. PubMed ID: 464378
    [Abstract] [Full Text] [Related]

  • 11. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 12. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.
    Collins CH, Yates MD, Uttley AH.
    J Hyg (Lond); 1985 Dec; 95(3):619-21. PubMed ID: 2936800
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM, Wallace RJ, Silcox VA, Thornsberry C.
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [Abstract] [Full Text] [Related]

  • 14. Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates.
    Koontz FP, Erwin ME, Barrett MS, Jones RN.
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):183-6. PubMed ID: 7821001
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H, Nakajima H, Kaminaga Y.
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR, Pankey GA, Wallace RJ, Jones DB.
    Rev Infect Dis; 1981 Jun; 3(5):1068-74. PubMed ID: 7339806
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.
    Casal MJ, Rodriguez FC, Luna MD, Benavente MC.
    Antimicrob Agents Chemother; 1987 Jan; 31(1):132-3. PubMed ID: 3105441
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.